Bayer Puerto Rico INC.

Reporting payments is a legal requirement; large totals often reflect large product portfolios.

$59Kgeneral payments (2019-2025)
$0.00research payments (2019-2025)
510clinicians paid

General and research payments are shown separately, never blended. Research payments are often institution-directed and tied to clinical trials.

General payments by year

2023 $16K
2024 $18K
2025 $25K

General payments only, as reported to CMS. Research payments are totaled above and not included in these bars.

Products most associated with its payments

Specialties it works with most

Hematology & Oncology $15K
Endocrinology, Diabetes & Metabolism $12K
Nephrology (Internal Medicine) $11K
Internal Medicine $7,215
Cardiovascular Disease $3,947
General Practice $2,825

Clinicians with the largest reported totals

Often long-running consulting, speaking, or advisory relationships, which companies must report by law. A large total is not evidence of anything improper.

ClinicianLocationSpecialtyGeneral payments (2019-2025)
Alex Gonzalez Bossolo San Juan, PR Endocrinology, Diabetes & Metabolism $849.30
Daiana Fernandez Gonzalez Ponce, PR Pediatrics $826.66
Francis Vazquez Roura Ponce, PR Nephrology (Internal Medicine) $826.66
Stephanie Colon-Lopez Bayamon, PR Nephrology (Internal Medicine) $765.34
Eddie Rodriguez Castro Toa Baja, PR Nephrology (Internal Medicine) $756.30
Angel Rivera Santos Ponce, PR Nephrology (Internal Medicine) $751.86
Ricardo Alicea-Guevara Toa Baja, PR Nephrology (Internal Medicine) $735.20
Enrique Maldonado Corchado Guaynabo, PR Endocrinology, Diabetes & Metabolism $678.97
Efrain Gonzalez-Arroyo Santurce, PR Endocrinology, Diabetes & Metabolism $671.39
Jannice Arroyo Soto Ponce, PR Nephrology (Internal Medicine) $647.54

Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.